Litcius/Paper detail

Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

Andrew L. Mammen, Anthony A. Amato, Mazen M. Dimachkie, Hector Chinoy, Yessar Hussain, James B Lilleker, Iago Pinal‐Fernandez, Yves Allenbach, Babak Boroojerdi, Mark Vanderkelen, Eumorphia Maria Delicha, Harold Koendgen, Ramin Farzaneh‐Far, Petra W. Duda, Camil Sayegh, Olivier Benvéniste, Anthony A. Amato, Olivier Benveniste, Suur Biliciler, Hector Chinoy, Mazen M. Dimachkie, Christyn Edmundson, Miriam Freimer, Anthony Geraci, Yessar Hussain, Pedro Machado, Andrew L. Mammen, Tahseen Mozaffar, Payam Soltanzadeh, Niraja Suresh, Anneke van der Kooi, Yves Allenbach, Matthew Appleby, Richard J Barohn, Nicolas Champtiaux, Christopher Doughty, Jerrica Farias, Constantine Farmakidis, Ali A. Habib, Chafic Karam, James Lilleker, Samantha Lorusso, Mamatha Pasnoor, Iago Pinal-Fernandez, Giorgia Querin, Joost Raaphorst, George Ransley, Sami Saba, Kazim Sheikh, Andrew Snedden, Jeffrey Statland, Tuan Vu

2023The Lancet Rheumatology55 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboMyopathyDouble blindInternal medicinePhysical therapyPathologyAlternative medicineInflammatory Myopathies and DermatomyositisMuscle and Compartmental DisordersPeripheral Neuropathies and Disorders